VivoSeq
Other

Depth of Anesthesia

5

Pipeline Programs

1

Active Trials

3

Companies Involved

Depth of Anesthesia is an early-stage landscape with 5 programs across 3 companies. The most active players are McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc., Fresenius Kabi Oncology Ltd., Pfizer's Upjohn has merged with Mylan to form Viatris Inc..

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

6/100

Mech. Concentration

40/100

Completion Rate

90/100

Attrition Rate

8/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

12

clinical trials

Completed9 · 75%
Unknown status1 · 8%
Terminated1 · 8%
Not yet recruiting1 · 8%

Trial Activity

12 trials

Depth of Anesthesia and Proteomics
Completed·HHeidelberg University·N/A·NCT05380778·18 enrolled
Propofol Induction Based on Lean Body Weight on the Depth of Anesthesia
Completed··Phase 4·NCT06862349·120 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)